Saleh, Ramy R.
Scott, Jordan L.
Meti, Nicholas https://orcid.org/0000-0001-8454-8484
Perlon, Danielle
Fazelzad, Rouhi
Ocana, Alberto
Amir, Eitan
Article History
Accepted: 4 January 2022
First Online: 1 February 2022
Declarations
:
: No sources of funding were used for the preparation of this article.
: Eitan Amir reports personal fees from Genentech/Roche, Apobiologix, Myriad Genetics, and Agendia, outside the submitted work. Ramy Saleh reports personal fees from Roche outside the submitted work. Jordan Scott reports no conflicts of interest. Danielle Perlon reports no conflicts of interest. Alberto Ocana reports personal fees from Daychi-Sankyo, Servier, Entrechem, and CancerAppy and travel support from Merck, outside the submitted work. Nicholas Meti reports no conflicts of interest. Rouhi Fazelzad reports no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: The data underlying this article will be shared on reasonable request to the corresponding author.
: Not applicable.
: Concept and design: all authors. Financial support: not applicable. Collection and assembly of data: RS and JLS. Data analysis and interpretation: all authors. Manuscript writing: all authors. Final approval of manuscript: all authors. RS and JS contributed equally as first author.